Factors affecting the pharmacokinetics of parenteral chloramphenicol in enteric fever. Journal of Antimicrobial and Chemotherapy 40, 91-8 (1997).
Pharmacokinetics of Piperaquine in Pregnant Women in Sudan with Uncomplicated Plasmodium falciparum Malaria. Am J Trop Med Hyg 87, 35-40 (2012).
Modeling the dynamics of Plasmodium vivax infection and hypnozoite reactivation in vivo. PLoS Negl Trop Dis 9, e0003595 (2015).
Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363, 9-17 (2004).
The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria. Malar J 8, 207 (2009).
Are Transporter Genes Other than the Chloroquine Resistance Locus (pfcrt) and Multidrug Resistance Gene (pfmdr) Associated with Antimalarial Drug Resistance?. Antimicrob Agents Chemother 49, 2180-2188 (2005).
Inferred relatedness and heritability in malaria parasites. Proc Biol Sci (2010). doi:10.1098/rspb.2010.0196
Microsatellite markers reveal a spectrum of population structures in the malaria parasite plasmodium falciparum. Molecular Biology and Evolution 17, 1467-82 (2000).
Geographical Distribution of Selected and Putatively Neutral SNPs in Southeast Asian Malaria Parasites. MOL BIOL EVOL 22, 2362-2374 (2005).
The suitability of laboratory-bred Anopheles cracens for the production of Plasmodium vivax sporozoites. Malar J 14, 312 (2015).
A Small Amount of Fat Does Not Affect Piperaquine Exposure in Patients with Malaria. Antimicrob. Agents Chemother. 55, 3971-3976 (2011).
Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries. Trop Med Int Health 16, 1167-1179 (2011)..
Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria. Eur J Clin Pharmacol (2010). doi:10.1007/s00228-010-0804-7
Malaria. Travel Med Infect Dis 4, 159-173 (2006)..
How much fat is necessary to optimize lumefantrine oral bioavailability?. Trop Med Int Health 12, 195-200 (2007).
Evaluation of three parasite lactate dehydrogenase-based rapid diagnostic tests for the diagnosis of falciparum and vivax malaria. Malar J 8, 241 (2009).
Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria. Antimicrob Agents Chemother 50, 2281-5 (2006).
Artemisinin-based combinations. Curr Opin Infect Dis 18, 531-6 (2005)..
Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. Journal of Infectious Diseases 190, 1773-82 (2004).
An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. Trop Med Int Health 11, 1653-60 (2006).
Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371, 411-23 (2014).
A Randomized, Controlled Study of a Simple, Once-Daily Regimen of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated, Multidrug-Resistant Falciparum Malaria. Clinical Infectious Diseases 41, 425-432 (2005).
Management of Multi Drug-Resistant Infections ( ) 319-39 (Humana Press Inc, 2004)..
In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health 11, 1898-9; author reply 1899 (2006).
Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria. Trop Med Int Health 12, 201-8 (2007).